List of Tables
Table 1. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Urology Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Urology Drugs Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Urology Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Urology Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Urology Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Urology Drugs Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Urology Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Urology Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Urology Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Urology Drugs Sales by Region (2018-2023) & (MT)
Table 18. Global Urology Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Urology Drugs Sales by Region (2024-2029) & (MT)
Table 20. Global Urology Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Urology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Urology Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Urology Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Urology Drugs Sales by Country (2018-2023) & (MT)
Table 27. North America Urology Drugs Sales by Country (2024-2029) & (MT)
Table 28. North America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Urology Drugs Sales by Country (2018-2023) & (MT)
Table 32. Europe Urology Drugs Sales by Country (2024-2029) & (MT)
Table 33. Europe Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Urology Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Urology Drugs Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Urology Drugs Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Urology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Urology Drugs Sales by Country (2018-2023) & (MT)
Table 42. Latin America Urology Drugs Sales by Country (2024-2029) & (MT)
Table 43. Latin America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Urology Drugs Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Urology Drugs Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Urology Drugs Sales (MT) by Type (2018-2023)
Table 51. Global Urology Drugs Sales (MT) by Type (2024-2029)
Table 52. Global Urology Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Urology Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Urology Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Urology Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Urology Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Urology Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Urology Drugs Price (USD/Kg) by Type (2018-2023)
Table 59. Global Urology Drugs Price (USD/Kg) by Type (2024-2029)
Table 60. Global Urology Drugs Sales (MT) by Application (2018-2023)
Table 61. Global Urology Drugs Sales (MT) by Application (2024-2029)
Table 62. Global Urology Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Urology Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Urology Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Urology Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Urology Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Urology Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Urology Drugs Price (USD/Kg) by Application (2018-2023)
Table 69. Global Urology Drugs Price (USD/Kg) by Application (2024-2029)
Table 70. Astellas Corporation Information
Table 71. Astellas Description and Business Overview
Table 72. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Astellas Urology Drugs Product
Table 74. Astellas Recent Developments/Updates
Table 75. Endo Corporation Information
Table 76. Endo Description and Business Overview
Table 77. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. Endo Urology Drugs Product
Table 79. Endo Recent Developments/Updates
Table 80. GP Pharm Corporation Information
Table 81. GP Pharm Description and Business Overview
Table 82. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. GP Pharm Urology Drugs Product
Table 84. GP Pharm Recent Developments/Updates
Table 85. Tolmar Corporation Information
Table 86. Tolmar Description and Business Overview
Table 87. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Tolmar Urology Drugs Product
Table 89. Tolmar Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Urology Drugs Distributors List
Table 93. Urology Drugs Customers List
Table 94. Urology Drugs Market Trends
Table 95. Urology Drugs Market Drivers
Table 96. Urology Drugs Market Challenges
Table 97. Urology Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urology Drugs
Figure 2. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Urology Drugs Market Share by Type in 2022 & 2029
Figure 4. Α (alpha) Blockers Product Picture
Figure 5. 5 α-reductase Inhibitors Product Picture
Figure 6. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Urology Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Urology Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Urology Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Urology Drugs Sales (2018-2029) & (MT)
Figure 14. Global Urology Drugs Average Price (USD/Kg) & (2018-2029)
Figure 15. Urology Drugs Report Years Considered
Figure 16. Urology Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Urology Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Urology Drugs Players: Market Share by Revenue in 2022
Figure 19. Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Urology Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Urology Drugs Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Urology Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Urology Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Urology Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Urology Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Urology Drugs Sales Market Share by Country (2018-2029)
Figure 45. Latin America Urology Drugs Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Urology Drugs Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Urology Drugs Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Urology Drugs by Type (2018-2029)
Figure 55. Global Revenue Market Share of Urology Drugs by Type (2018-2029)
Figure 56. Global Urology Drugs Price (USD/Kg) by Type (2018-2029)
Figure 57. Global Sales Market Share of Urology Drugs by Application (2018-2029)
Figure 58. Global Revenue Market Share of Urology Drugs by Application (2018-2029)
Figure 59. Global Urology Drugs Price (USD/Kg) by Application (2018-2029)
Figure 60. Urology Drugs Value Chain
Figure 61. Urology Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed